China
· Delayed Price · Currency is CNY Pacific Shuanglin Bio-pharmacy Co., LTD Company Description
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.
Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), hepatitis B human immunoglobulin, tetanus human immunoglobulin, rabies patient immunoglobulin, and human coagulation factor.
addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; and electronic product information consultation.
The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021.
Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is based in Taiyuan, China.
| Country | China |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,426 |
| CEO | Xiankui Rong |
Contact Details
Address: Sunshine City Global Financial Center Taiyuan, 030000 China | |
| Phone | 86 75 9293 1218 |
| Website | slbiop.com |
Stock Details
| Ticker Symbol | 000403 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000F14 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yehong Wang | Chief Financial Officer and Accounting Supervisor |
| Lei Yan | Deputy GM and Director |
| Wenbin Si | Deputy GM and Non-Independent Director |
| Xiaoying Huang | Deputy GM and Non-Independent Director |
| Lan Ye | Deputy GM and Non-Independent Director |
| Yulin Zhao | Board Secretary |
| Xiankui Rong | General Manager |